Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - Gemini Therapeutics, Inc. /DE | fs12020_fsdevelopmentcorp.htm |
| EX-99.6 - CONSENT OF DEEPA PAKIANATHAN - Gemini Therapeutics, Inc. /DE | fs12020ex99-6_fsdevelopment.htm |
| EX-99.5 - CONSENT OF DANIEL DUBIN - Gemini Therapeutics, Inc. /DE | fs12020ex99-5_fsdevelopment.htm |
| EX-23.1 - CONSENT OF WITHUMSMITH+BROWN, PC. - Gemini Therapeutics, Inc. /DE | fs12020ex23-1_fsdevelopment.htm |
Exhibit 99.4
Consent to be Named as a Director Nominee
In connection with the filing by FS Development Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of FS Development Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| Dated: July 24, 2020 |
/s/ Robert Carey |
|
| Robert Carey |